(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

COMPOSTOS DE ÁCIDO NUCLEICO MODIFICADO POR LIPÍDEO E MÉTODOS

Em AnáliseInvention PatentPCT · US2019034724

Application data

Number

112020024426

Type

Invention Patent

Filing

05/30/2019

Publication

03/23/2021

PCT

US2019034724

Progress at the INPI

Technical opinion to answer
  1. Filing05/30/19
  2. Publication03/23/21
  3. Examination
  4. Allowance
  5. Grant
  6. In force

The INPI issued a technical opinion on patentability. The applicant must respond for examination to continue.

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 10/08/2024. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

DTX PHARMA, INC.

US

NOVARTIS AG

CH

Inventors

A. S. (pessoa física)

US

F. T. (pessoa física)

US

Technical data

IPC Classification

Priority claims

US

62/678,013 · 05/30/2018

US

62/793,597 · 01/17/2019

Abstract

COMPOSTOS DE ÁCIDO NUCLEICO MODIFICADO POR LIPÍDEO E MÉTODOS''. São revelados no presente documento, entre outros, compostos de ácido nucleico modificados por lipídeo da seguinte estrutura, sua preparação e seu uso: (I).

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Transferência deferida

#25.1

10/08/2024

RPI 2805

Parecer de pré-exame

#6.23

03/28/2023

RPI 2725

Alteração de sede deferida

#25.7

07/20/2021

RPI 2637

Notificação de entrada na fase nacional - PCT

#1.3

03/23/2021

RPI 2620

Alteração de dados cadastrais

#1.1

12/15/2020

RPI 2606

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.